Recent Finacing
Recent Raise
Oyster Point Pharma is a clinical-stage company developing ocular surface‑sparing nasal sprays (nAChR agonists OC‑01/OC‑02) that stimulate the trigeminal parasympathetic pathway to increase tear production for dry eye.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
